Biohaven Pharmaceutical Holding Company Ltd. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0aa15eb1-dbf1-470f-9d87-e9628d855e9f/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-704.0M | 2021-01-01 – 2021-12-31 | evidence 0001689813-22-000014 |
| FY 2020 | $-645.4M | 2020-01-01 – 2020-12-31 | evidence 0001689813-21-000024 |
| FY 2019 | $-479.1M | 2019-01-01 – 2019-12-31 | evidence 0001689813-20-000016 |
| FY 2018 | $-224.6M | 2018-01-01 – 2018-12-31 | evidence 0001689813-19-000014 |
| FY 2017 | $-107.6M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-001326 |
| FY 2016 | $-60.6M | 2016-01-01 – 2016-12-31 | evidence 0001047469-18-001326 |
| FY 2015 | $-9.7M | 2015-01-01 – 2015-12-31 | evidence 0001047469-18-001326 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Biohaven Pharmaceutical Holding Company Ltd. — all facts · Revenue · Net Income